| | | | By Ed Silverman Adobe “A rejection of the petition will encourage more aggressive pricing of drugs," wrote two cancer patients to the HHS. Read More | By John Wilkerson Adobe The generic drug industry’s lobbying group, the Association for Accessible Medicines, fired its president Dan Leonard, three sources said. Read More | By Bob Herman Adobe UnitedHealth Group expects to funnel more of the insurance premiums it collects from workers and taxpayers toward itself next year. Read More | Sponsored Insight by Pfizer Why scientists are sprinting toward new treatments for blood disorders Millions of people around the world suffer from blood disorders today, while scientists race to find new treatments and potential cures. In December, blood disorder specialists from around the globe will convene in New Orleans to share research and medical advances at the 64th annual meeting of the American Society of Hematology. Among them will be Pfizer scientists, who will be sharing more than 30 abstracts across Pfizer's hematology portfolio. Learn more about what they have to say. | By Scott Gottlieb and Mark B. McClellan ARIS MESSINIS/AFP via Getty Images By passing proposed legislation, Congress would help the FDA gain better oversight of diagnostic tests and cosmetics. Read More | By Tara Bannow Adobe Medical malpractice lawsuits were held up as court dockets ground to a halt during the pandemic. Now, they're catching up with hospitals. Read More | |
No comments